SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001104659-23-104818
Filing Date
2023-09-28
Accepted
2023-09-28 17:17:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC14D9C tm2327166d1_sc14d9c.htm SC14D9C 18365
2 EXHIBIT 99.1 tm2327166d1_ex99-1.htm EX-99.1 10854
  Complete submission text file 0001104659-23-104818.txt   30948
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filed by) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-87033 | Film No.: 231290889
SIC: 2834 Pharmaceutical Preparations